Engineering less immunogenic and antigenic FVIII proteins.
about
Unraveling the Effect of Immunogenicity on the PK/PD, Efficacy, and Safety of Therapeutic ProteinsRational design of low immunogenic anti CD25 recombinant immunotoxin for T cell malignancies by elimination of T cell epitopes in PE38.Design and engineering of deimmunized biotherapeutics.T cells from hemophilia A subjects recognize the same HLA-restricted FVIII epitope with a narrow TCR repertoire.Development of a strategy and computational application to select candidate protein analogues with reduced HLA binding and immunogenicity.
P2860
Engineering less immunogenic and antigenic FVIII proteins.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Engineering less immunogenic and antigenic FVIII proteins.
@en
type
label
Engineering less immunogenic and antigenic FVIII proteins.
@en
prefLabel
Engineering less immunogenic and antigenic FVIII proteins.
@en
P2860
P1433
P1476
Engineering less immunogenic and antigenic FVIII proteins.
@en
P2093
Kathleen P Pratt
P2860
P356
10.1016/J.CELLIMM.2015.10.008
P577
2015-11-02T00:00:00Z